v1
A phase I/II dose-escalation trial of bevacizumab in previously treated metastatic breast cancer.
Identifier:nobleid.org/w1/20260515/F3FF3797
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/F3FF3797)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →